CVE-2023-42666

—

CVSS 3.1

5.3 medium

EPSS

<1%p32

Published

Oct 19, 2023 (Oct 19, 2023)

Modified

Jun 17, 2026

Description

The affected product is vulnerable to an exposure of sensitive information to an unauthorized actor vulnerability, which may allow an attacker to create malicious requests for obtaining the information of the version about the web server used.

Vendors: dexma
Products: dexgate
Weakness: CWE-200
Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N

NVD CVE.org GitHub PoCs EPSS (0.4%)

In the news0 stories

No ingested article mentions this CVE yet.